Cart
sales@molnova.com
NSC624548
CAS No. 105128-93-6
NSC624548 ( HO-221;HO 221;NSC 624548 )
Catalog No. M10246 CAS No. 105128-93-6
A small molecule that inhibits the activities of E. coli DNA polymerase I and calf thymus DNA polymerase alpha.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNSC624548
-
NoteResearch use only, not for human use.
-
Brief DescriptionA small molecule that inhibits the activities of E. coli DNA polymerase I and calf thymus DNA polymerase alpha.
-
DescriptionA small molecule that inhibits the activities of E. coli DNA polymerase I and calf thymus DNA polymerase alpha.
-
SynonymsHO-221;HO 221;NSC 624548
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number105128-93-6
-
Formula Weight492.67
-
Molecular FormulaC18H11BrClN5O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1=CC=C(C(=C1)C(=O)NC(=O)NC2=CC(=C(C=C2)OC3=NC=C(C=N3)Br)Cl)[N+](=O)[O-]
-
Chemical NameN-((4-((5-bromopyrimidin-2-yl)oxy)-3-chlorophenyl)carbamoyl)-2-nitrobenzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Abdel-Aziz W, et al. Invest New Drugs. 2003 Nov;21(4):421-8.
molnova catalog
related products
-
VXc-486
VXc-486 (VXc486) is a novel inhibitor of gyrase B, potently inhibits multiple drug-sensitive isolates and drug-resistant isolates of Mycobacterium tuberculosis in vitro.
-
Lactoferrin 17-41
This is amino acids 17 to 41 fragment of lactoferrin, known as lactoferricin B. This peptide shows anti-fungal properties in combination of other anti-fungal agents.Candida Albicans is one of the targets of the lactoferricin B.
-
Ozenoxacin
Ozenoxacin is a quinolone antibacterial. It shows potent activities against the main microorganisms isolated from soft tissue and skin infections.
